Literature DB >> 28150319

Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection.

Gagan Mathur1, Sarah L Mott2, Laura Collins1, Gail A Nelson1, C Michael Knudson1, Annette J Schlueter1.   

Abstract

BACKGROUND: Platelet clumping is a common occurrence during peripheral blood hematopoietic stem cell (HSC) collection using the Spectra Optia mononuclear cell (MNC) protocol. If clumping persists, it may prevent continuation of the collection and interfere with proper MNC separation. This study is the first to report the incidence of clumping, identify precollection factors associated with platelet clumping, and describe the degree to which platelet clumping interferes with HSC product yield. STUDY DESIGN AND METHODS: In total, 258 HSC collections performed on 116 patients using the Optia MNC protocol were reviewed. Collections utilized heparin in anticoagulant citrate dextrose to facilitate large-volume leukapheresis. Linear and logistic regression models were utilized to determine which precollection factors were predictive of platelet clumping and whether clumping was associated with product yield or collection efficiency.
RESULTS: Platelet clumping was observed in 63% of collections. Multivariable analysis revealed that a lower white blood cell count was an independent predictor of clumping occurrence. Chemotherapy mobilization and a lower peripheral blood CD34+ cell count were predictors of the degree of clumping. Procedures with clumping had higher collection efficiency but lower blood volume processed on average, resulting in no difference in collection yields. Citrate toxicity did not correlate with clumping.
CONCLUSION: Although platelet clumping is a common technical problem seen during HSC collection, the total CD34+ cell-collection yields were not affected by clumping. WBC count, mobilization approach, and peripheral blood CD34+ cell count can help predict clumping and potentially drive interventions to proactively manage clumping.
© 2017 AABB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28150319      PMCID: PMC5769924          DOI: 10.1111/trf.14022

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  16 in total

1.  Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?

Authors:  A Gidron; A Verma; M Doyle; L Boggio; A Evens; L Gordon; S Singhal; M Tallman; S Williams; J Winter; J Mehta
Journal:  Bone Marrow Transplant       Date:  2005-02       Impact factor: 5.483

Review 2.  Hematopoietic stem-cell transplantation.

Authors:  Edward A Copelan
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

3.  Prophylactic low dose continuous calcium infusion during peripheral blood stem cell (PBSC) collections to reduce citrate related toxicity.

Authors:  Vikas Hegde; Rasika Setia; Shivkumar Soni; Anil Handoo; Sanjeev Kumar Sharma; Dharma Chaudhary; Meenu Kapoor
Journal:  Transfus Apher Sci       Date:  2016-02-15       Impact factor: 1.764

4.  Factors influencing platelet reactivity in patients undergoing coronary artery bypass surgery.

Authors:  David J Schneider; Sreedivya Chava
Journal:  Coron Artery Dis       Date:  2016-05       Impact factor: 1.439

5.  Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors.

Authors:  Miguel A Canales; Rosario Arrieta; Ruben Gomez-Rioja; Jesus Diez; Victor Jimenez-Yuste; Fernando Hernandez-Navarro
Journal:  J Hematother Stem Cell Res       Date:  2002-08

6.  Comparative evaluation of a heparin-citrate anticoagulation for LDL-apheresis in two primary apheresis systems.

Authors:  Doris Handschel; Michiel Etienne Janssens; Marion Gericke; Stef De Reys; Helmut Borberg
Journal:  J Clin Apher       Date:  2016-09-27       Impact factor: 2.821

7.  Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.

Authors:  L S Schwartzberg; R Birch; B Hazelton; K W Tauer; P Lee; R Altemose; C George; R Blanco; F Wittlin; J Cohen
Journal:  J Hematother       Date:  1992

8.  Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

Review 9.  Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

Authors:  Sergio Giralt; Luciano Costa; Jeffrey Schriber; John Dipersio; Richard Maziarz; John McCarty; Paul Shaughnessy; Edward Snyder; William Bensinger; Edward Copelan; Chitra Hosing; Robert Negrin; Finn Bo Petersen; Damiano Rondelli; Robert Soiffer; Helen Leather; Amy Pazzalia; Steven Devine
Journal:  Biol Blood Marrow Transplant       Date:  2013-10-17       Impact factor: 5.742

10.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Authors:  Isabelle Petit; Martine Szyper-Kravitz; Arnon Nagler; Meir Lahav; Amnon Peled; Liliana Habler; Tanya Ponomaryov; Russell S Taichman; Fernando Arenzana-Seisdedos; Nobutaka Fujii; Judith Sandbank; Dov Zipori; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2002-06-17       Impact factor: 25.606

View more
  2 in total

1.  Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.

Authors:  Scott T Avecilla; Farid Boulad; Karina Yazdanbakhsh; Michel Sadelain; Patricia A Shi
Journal:  Transfusion       Date:  2021-06-23       Impact factor: 3.337

2.  PAR4-Mediated PI3K/Akt and RhoA/ROCK Signaling Pathways Are Essential for Thrombin-Induced Morphological Changes in MEG-01 Cells.

Authors:  Yunkyung Heo; Hyejin Jeon; Wan Namkung
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.